“Evaluation of 2-(4-Chlorophenyl)-4-(4-Fluorophenyl)-5-Pyridin-4-Yl-1,2-Dihydropyrazol-3-One As a p38 MAPK Inhibitor in MCF-7 and MDA-MB-231 Breast Cancer Cell Lines”. Al Mustansiriyah Journal of Pharmaceutical Sciences 25, no. 3 (August 31, 2025): 317–326. Accessed June 28, 2026. https://ajps.uomustansiriyah.edu.iq/index.php/AJPS/article/view/1224.